Wang Chen

[Expert Profile] Wang Chen, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Engineering, is an authoritative expert in respiratory medicine in China. He has long been dedicated to clinical diagnosis, treatment, and scientific research of idiopathic pulmonary fibrosis, sarcoidosis, pulmonary alveolar proteinosis, and other difficult respiratory diseases, and is an important leader in respiratory medicine and medical education in China.

[Education & Career] Professor Wang Chen graduated from Capital Medical University, and has been deeply engaged in the field of respiratory medicine for decades. He has long served as President of Beijing Chao-Yang Hospital, President of China-Japan Friendship Hospital, and President of Peking Union Medical College. He was elected as an Academician of the Chinese Academy of Engineering in 2013. He has held important academic positions including Chair of the Respiratory Diseases Branch of the Chinese Medical Association and member of relevant expert committees of the World Health Organization (WHO). He has presided over major projects including the National Key R&D Program, and is an academic leader in the field of respiratory medicine in China.

[Areas of Expertise] Professor Wang specializes in the diagnosis and treatment of interstitial lung diseases and difficult respiratory conditions such as idiopathic pulmonary fibrosis, sarcoidosis, and pulmonary alveolar proteinosis, as well as standardized management of common respiratory diseases such as COPD and asthma. He has profound expertise in precise differential diagnosis of interstitial lung diseases, standardized application of anti-fibrotic drugs (pirfenidone, nintedanib, etc.), and comprehensive assessment of pulmonary function and imaging. He excels at managing difficult cases of "dyspnea and diffuse pulmonary lesions," helping numerous difficult respiratory patients receive clear diagnoses and slow disease progression.

[Academic Achievements & Industry Contributions] Professor Wang has led the establishment of China's respiratory disease clinical research system, presided over multiple major national respiratory disease research projects, systematically evaluating the epidemiological status and prevention/treatment strategies of COPD, asthma, pulmonary embolism, and related conditions in China, with findings published in top international journals. He has led the development of multiple Chinese respiratory disease diagnosis and treatment guidelines, actively promoted "standardized respiratory department construction" and tobacco control, and advocated for the establishment of a nationwide respiratory disease prevention network. In fighting major respiratory infectious diseases, he has repeatedly served as a core member of expert panels, providing important scientific recommendations for epidemic prevention and control, and making outstanding contributions to the development of respiratory medicine in China and globally.

[Clinical Practice & Outstanding Contributions] For decades on the respiratory clinical front lines, Professor Wang has treated tens of thousands of patients with various difficult respiratory diseases, and his team has reached an internationally advanced level in the fields of interstitial lung disease and pulmonary embolism. He has received multiple national awards including the National Science and Technology Progress Award, and has been repeatedly recognized as a national advanced worker. He is a truly deserving leading figure in the field of respiratory medicine in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Wang Chen serves as President of the Chinese Academy of Medical Sciences and Peking Union Medical College, and Academician of the Chinese Academy of Engineering, among other positions. He has presided over national-level major projects including the National Key R&D Program, and is an authoritative expert in the fields of respiratory medicine and public health in China. He led the completion of national epidemiological surveys on COPD, asthma, pulmonary embolism, and related diseases in China, led the development of multiple respiratory disease diagnosis and treatment guidelines, actively promoted standardized construction of the Department of Pulmonary and Critical Care Medicine (PCCM) and tobacco control, and repeatedly served as a core member of national expert panels in major respiratory infectious disease prevention and control, providing key scientific recommendations for epidemic response. He has received multiple national awards including the National Science and Technology Progress Award, trained a large number of respiratory medicine leaders, and is a flagship figure in the field of respiratory medicine in China.